1-3 of 3
percutaneous nephrolithotomy
Close
Sort by
Journal Articles

Primary Central Nervous System Lymphoma Treatment Outcomes-a Decade's Experience from a Single Centre in Riyadh, Saudi Arabia

Imran K Tailor, MBBS, MD FRCP, FRCPath, Taimoor Hussain, MBBS FCPS, Wafa Shakweer, Ibraheem H Motabi, MRCP MD, Ghulam Murtaza, MBBS, FCPS, Syed Ziauddin A. Zaidi, MBBS, FRCP, FRCPath, FACP, Nawal F Shehry, Mubarak S. AlGhamdi, MD, Yasser Bayoumi, MD, Samer Mudaibigh, MD SBIM, SBAH
Journal: Blood
Blood (2016) 128 (22): 5416.
https://doi.org/10.1182/blood.V128.22.5416.5416
Published: 2016
Journal Articles

Population Based Analysis of Outcomes of Primary Central Nervous System Lymphoma (PCNSL) Suggests a Treatment Strategy Including Intensive Chemotherapy with Autologous Stem Cell Transplantation Provides a Survival Advantage for Patients <65 Years of Age

Joanna Graczyk, MD FRCPC, Sunita Ghosh, PhD, Neil Chua, MD FRCPC, Douglas A. Stewart, MD FRCPC, Carolyn J. Owen, MD FRCPC
Journal: Blood
Blood (2014) 124 (21): 2520.
https://doi.org/10.1182/blood.V124.21.2520.2520
Published: 2014
Journal Articles

First Use of Temozolomide in Primary Intra-Ocular Lymphoma (PIOL): a Very Well Tolerated and Potentially Effective Treatment.

Mohamed Mesmoudi, Nathalie Cassoux, Veronique Leblond, Helene Merle-Beral, Sylvie Baudet, Sylvain Choquet
Journal: Blood
Blood (2009) 114 (22): 4760.
https://doi.org/10.1182/blood.V114.22.4760.4760
Published: 2009